Overview

24 Hour IOP Lowering Efficacy of AL-3789

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP was measured every 4 hours, beginning at 8 AM for 24 hours.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Criteria
Inclusion Criteria:

- Diagnosis of open-angle glaucoma and treated for at least 30 days prior to Screening
Visit with a topical prostaglandin analog as monotherapy.

- Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

- Pregnant, intend to become pregnant, breastfeeding.

- Difference in IOP greater than 3 mm Hg between eyes at Screening Visit.

- Any form of glaucoma other than open-angle glaucoma.

- Other protocol-defined exclusion criteria may apply.